14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $28.76 $33.00 Wednesday, 24th Apr 2024 GLPG stock ended at $28.77. This is 2.31% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.12% from a day low at $28.76 to a day high of $29.37.
90 days $28.76 $40.34
52 weeks $28.76 $45.16

Historical Galapagos NV prices

Date Open High Low Close Volume
Dec 04, 2020 $123.01 $123.03 $120.87 $121.65 107 472
Dec 03, 2020 $123.61 $123.85 $122.47 $122.64 65 745
Dec 02, 2020 $124.67 $125.85 $123.86 $124.82 105 991
Dec 01, 2020 $128.32 $129.03 $126.25 $127.19 199 149
Nov 30, 2020 $125.39 $125.76 $122.20 $122.61 109 235
Nov 27, 2020 $123.44 $125.90 $123.44 $125.84 108 542
Nov 25, 2020 $121.00 $121.97 $120.37 $120.78 105 910
Nov 24, 2020 $124.77 $125.25 $123.20 $123.54 99 078
Nov 23, 2020 $125.56 $125.61 $123.90 $125.25 91 612
Nov 20, 2020 $123.78 $125.23 $123.62 $124.67 213 412
Nov 19, 2020 $123.01 $123.59 $122.28 $123.38 114 206
Nov 18, 2020 $125.38 $125.58 $123.84 $123.95 140 220
Nov 17, 2020 $125.83 $125.94 $124.38 $125.25 102 693
Nov 16, 2020 $127.28 $127.28 $125.01 $125.70 78 733
Nov 13, 2020 $125.15 $125.92 $124.24 $124.88 268 812
Nov 12, 2020 $125.53 $126.35 $123.72 $124.07 190 248
Nov 11, 2020 $123.91 $124.28 $122.07 $123.98 130 424
Nov 10, 2020 $123.15 $123.15 $120.99 $122.17 153 039
Nov 09, 2020 $124.06 $124.11 $121.41 $122.40 234 920
Nov 06, 2020 $122.06 $122.27 $118.84 $119.31 171 319
Nov 05, 2020 $128.97 $129.00 $125.88 $126.41 177 175
Nov 04, 2020 $125.24 $127.81 $124.64 $125.48 449 360
Nov 03, 2020 $119.09 $121.46 $118.63 $120.51 372 843
Nov 02, 2020 $115.61 $115.79 $113.03 $114.53 358 480
Oct 30, 2020 $119.07 $119.07 $116.17 $116.48 176 337
Click to get the best stock tips daily for free!

About Galapagos NV

Galapagos NV Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The compan... GLPG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT